Vivos Therapeutics, Inc (VVOS) - Net Sales Margin

Vivos Therapeutics Inc. (VVOS) - corporate logo

High patent barriers and insurance reimbursement complexities limit access to the sleep apnea treatment niche. In GURU.Markets, the net profit yield reflects a breakout driven by FDA approval of CARE systems and the expansion of the clinic network. Vivos Therapeutics (VVOS) innovations are displacing cumbersome alternatives, and the value of -107.20 serves as the current indicator of the company's sales margins.

Vivos Therapeutics Inc (VVOS) - Return on Sales by Net Profit from 07/04/2022 to 11/20/2026

Financial and market metric breakdowns for Vivos Therapeutics (VVOS)

Summary company analytics:Vivos Therapeutics Inc - VVOS
Manufactured product of Vivos Therapeutics Inc

Operational business resilience is determined by the efficiency of converting revenue into net profit. This metric measures the portion of income remaining after deducting all operating and financial expenses. For Vivos Therapeutics (VVOS), this reflects the profitability of implementing non-surgical apnea treatment systems and ancillary services. Stable demand for devices directly impacts profit dynamics. By analyzing current net profit margins, an investor assesses the company's ability to scale the business.

Analysis of competing companies

BSX: Net Sales Margin|Return on Sales by Net Profit Edwards Lifesciences Corporation|RMD (ResMed Corporation) - Net Sales Margin|OmniPod (PODD) - Company Sales Margin|Net Sales Margin ZBH|Net Sales Margin coopercos.com (COO)|Net Sales Margin ALGN (aligntech.com)|Net Sales Margin Globus Medical Inc GMED|TMDX - Net Margin|ATEC: Net Margin|AORT (Artivion, Inc.) - Return on Sales by Net Profit|Enovis Corporation - Net Profit Rate|IART (Integra LifeSciences Inc.) - Net Sales Margin|Net Margin Establishment Labs Corp ESTA|Net Margin Beta Bionics, Inc. (BBNX)|IRADIMED CORPORATION (IRMD) - Net Profitability Margin|Embecta Health - Return on Sales by Net Profit|Net Sales Margin Tandem Diabetes Care TNDM|AxoGen Inc - Net Sales Margin|Company Sales Margin SI-BONE Inc SIBN|Orthofix (OFIX) - Net Margin|Return on Sales by Net Profit Bioventus Corp|Net Margin orthopediatrics.com|Return on Sales by Net Profit Treace Medical Concepts (TMCI)|Net Sales Margin SRTA|CARL - Net Margin|Net Margin RxSight, Inc. RXST|CLPT: Net Return on Sales|STXS: Return on Sales by Net Profit|neurostar.com - Company Net Profitability|Sight Sciences Inc. (SGHT) - Net Margin|Net Margin orchestrabiomed.com (OBIO)|Net Margin Anika Therapeutics, Inc.|Net Return on Sales NSPR (InspireMD Inc.)|Net Margin Jin Medical International Ltd (ZJYL)|Net Margin VANI (Vivani Medical)|Net Margin xtantmedical.com XTNT|Net Profit Rate NMTC|MODD - Net Margin|Net Profit Rate MYO (Myomo, Inc)|COCH (Envoy Medical, Inc.) - Return on Sales by Net Profit|Net Return on Sales NVNO|Return on Sales by Net Profit SINT|Return on Sales by Net Profit Tenon Medical (TNON)|Net Margin ReWalk Robotics Ltd (LFWD)|Company Sales Margin Autonomix|Net Sales Margin IVF (invobioscience.com)|bonebiologics.com - Net Margin|AXNX - Net Margin|BIOL (BIOLASE) - Net Return on Sales|Dynatronics Corporation (DYNT) - Net Margin|Net Return on Sales FNA|INVO (INVO Bioscience Inc.) - Net Sales Margin